Topiramate effects on plasma serotonin levels in children with epilepsy

Epilepsy Research

Volumn 81, Issue 2-3, 2008, Pages 148-154

  Grosso, Salvatore ^a   Blardi, Patrizia ^a   Battaglini, Marco ^a   Franzoni, Emilio ^b   De Lalla, Arianna ^a   Mostardini, Rosa ^a   Balestri, Paolo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiepileptic drug; Epilepsy; Platelets; Serotonin; Topiramate

Indexed keywords

BENZODIAZEPINE DERIVATIVE; PHENOBARBITAL; PHENYTOIN; SEROTONIN; TOPIRAMATE; VALPROIC ACID;

ANOREXIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; EPILEPSY; FEMALE; HUMAN; IRRITABILITY; MALE; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; SIDE EFFECT; WEIGHT; WEIGHT REDUCTION;

ANTICONVULSANTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; LINEAR MODELS; MALE; SEROTONIN; TIME FACTORS;

EID: 53249113361     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.05.007     Document Type: Article

References (29)

1. Alvarez J.C., Sanceaume M., Advenier C., and Spreux-Varoquaux O. Differential changes in brain and platelet 5HT concentration after steady state achievement and repeated administration of antidepressant drugs in mice. Eur. Neuropsychopharmacol. 10 (1999) 31-36
2. Arnone D. Review of the use of Topiramate for treatment of psychiatric disorders. Ann. Gen. Psychiatry 4 (2005) 5
3. Blardi P., De Lalla A., Leo A., Auteri A., Iapichino S., Di Muro A., Dell'Erba A., and Castrogiovanni P. Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients. J. Clin. Psychopharmacol. 22 (2002) 131-136
4. Bordukalo-Niksic T., Cicin-Sain L., and Jernej B. Expression of brain and platelet serotonin transporters in sublines of rats with constitutionally altered serotonin homeostasis. Neurosci. Lett. 369 (2004) 44-49
5. Brewerton T.D. Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology 20 (1995) 561-590
6. Castrogiovanni P., Blardi P., De Lalla A., Dell'Erba A., and Auteri A. Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?. Psychopharmacol. Bull. 37 (2003) 102-108
7. Cavalheiro E.A., Fernandes M.J., Turski L., and Naffah-Mazzacoratti M.G. Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus. Epilepsia 35 (2004) 1-11
8. Chugani D.C. Serotonin in autism and pediatric epilepsies. Ment. Retard. Dev. Disabil. Res. Rev. 10 (2004) 112-116
9. Chugani H.T., and Chugani D.C. Imaging of serotonin mechanisms in epilepsy. Epilepsy Curr. 5 (2005) 201-206
10. Cupello A., Favale E., Audenino D., Scarrone S., Gastaldi S., and Albano C. Decrease of serotonin transporters in blood platelets after epileptic seizures. Neurochem. Res. 30 (2005) 425-428
11. 2+. Eur. J. Pharmacol. 328 (1997) 153-162
12. Delorme R., Betancur C., Callebert J., Chabane N., Laplanche J.L., Mouren-Simeoni M.C., Launay J.M., and Leboyer M. Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder. Neuropsychopharmacology 30 (2005) 1539-1547
13. Grosso S., Farnetani M.A., Berardi R., Di Bartolo R., Magi L., Morgese G., and Balestri P. Dexfenfluramine effective in drug-resistant temporal lobe epilepsy. Neurology 25 (2001) 1139-1140
14. Grosso S., Galimberti D., Farnetani M.A., Cioni M., Mostardini R., Vivarelli R., Di Bartolo R.M., Bernardoni E., Berardi R., Morgese G., and Balestri P. Efficacy and safety of topiramate in infants according to epilepsy syndromes. Seizure 14 (2005) 183-189
15. Grosso S., Franzoni E., Iannetti P., Incorpora G., Cardinali C., Toldo I., Verrotti A., Caterina Moscano F., Lo Faro V., Mazzone L., Zamponi N., Boniver C., Spalice A., Parisi P., Morgese G., and Balestri P. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study. J. Child Neurol. 20 (2005) 893-897
16. Jakovljevic M., Muck-Seler D., Pivac N., Ljubicic D., Bujas M., and Dodig G. Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia. Biol. Psychiatry 41 (1997) 1028-1034
17. Jobe P.C. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav. 4 Suppl. (3) (2003) 14-24
18. Jovic N.J., Mirkovic D., Majkic-Singh N., and Milovanovic D.D. Plasma and urinary serotonin and 5-HIAA in children treated with lamotrigine for intractable epilepsy. Adv. Exp. Med. Biol. 467 (1999) 297-302
19. Lesch K.P., Wolozin B.L., Murphy D.L., and Reiderer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J. Neurochem. 60 (1993) 2319-2322
20. Lowenstein D.H. Recent advances related to basic mechanisms of epileptogenesis. Epilepsy Res. Suppl. 11 (1996) 45-60
21. Muck-Seler D., Bujas M., Ljubic-Thibal V., and Jakovljevic M. Effect of age on platelet 5-HT concentrations in healthy controls, depressed and schizophrenic patients. Neuropsychobiology 34 (1996) 201-203
22. Nagata E., Shibata M., Hamada J., Shimizu T., Katoh Y., Gotoh K., and Suzuki N. Plasma 5-hydroxytryptamine (5-HT) in migraine during an attack-free period. Headache 46 (2006) 592-596
23. Perucca E. New anti-epileptic drugs-fifth Eilat conference. Drugs 3 (2000) 1149-1153
24. Pletscher A., and Laubscher A. Blood platelets as models for neurons: uses and limitations. J. Neural Transm. 16 (1980) 7-16
25. Rausch J.L., Johnson M.E., Li J., Hutcheson J., Carr B.M., Corley K.M., Gowans A.B., and Smith J. Serotonin transport kinetics correlated between human platelets and brain synaptosomes. Psychopharmacology (Berl.) 180 (2005) 391-398
26. Savic I., Lindstrom P., Gulyas B., Halldin C., Andree B., and Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 62 (2004) 1343-1351
27. Tagari P.C., Boullin D.J., and Davies C.L. Simplified determination of serotonin in plasma by liquid chromatography with electrochemical detection. Clin. Chem. 30 (1984) 131-135
28. Uebelhack R., Franke L., Herold N., Plotkin M., Amthauer H., and Felix R. Brain and platelet serotonin transporter in humans-correlation between [123I]-ADAM SPECT and serotonergic measurements in platelets. Neurosci. Lett. 406 (2006) 153-158
29. White H.S. Molecular pharmacology of topiramate: managing seizures and preventing migraine. Headache 45 Suppl. (1) (2005) 48-56